SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as investors analyze strong second-quarter revenue results and a larger-than-expected increase in capital expenditures, sparking debate about whether this is a "sell the news" event or a sign of sustained AI-driven growth. Community discussion is heavily focused on the company's upcoming earnings call, with traders closely monitoring guidance to determine if TSMC's dominant market position can overcome broader sector volatility and macro concerns.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility following a surprise $1B convertible debt offering, with investors debating whether the capital injection is a strategic move to accelerate launch capabilities or a breach of trust regarding previous dilution guidance. Community discourse remains sharply divided between long-term believers who view the dip as a generational buying opportunity and critics concerned about management's communication and the potential for short-term downward pressure from convertible arbitrage.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

AtaiBeckley shares are surging following widespread reports that Eli Lilly is in advanced talks to acquire the psychedelic drugmaker. While the potential buyout has triggered significant community optimism and debate over fair valuation, investors are also closely monitoring the sector's regulatory progress and potential interest from other major pharmaceutical suitors.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as retail investors debate whether its sharp price decline represents a generational buying opportunity or a deeper structural failure driven by recent leadership changes and shifting consumer sentiment. The community is heavily split between bulls calling for a potential private equity takeover due to the company's strong balance sheet and bears warning of further downside as the brand struggles to maintain its cultural edge.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors debate the impact of a recent $125 million convertible note offering, which has sparked intense discussion regarding potential dilution and the company's capital allocation strategy. While some community members view the financing as a necessary step to fund large-scale data center contracts, many retail investors are expressing frustration over the stock's sharp decline and ongoing concerns about management's communication and institutional support.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending following a notable endorsement from President Trump, which has sparked immediate retail and institutional interest while the stock remains a central focus for the AI server infrastructure trade. The community is actively debating the stock's long-term leadership status, with many highlighting its potential for a massive breakout as AI hardware demand continues to reshape enterprise IT spending.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is facing intense volatility following a significant pre-earnings revenue miss, as investors react to management's comments regarding a shift in enterprise spending from software toward AI-related infrastructure. The community is heavily divided, with some traders debating the validity of the three-day rule and technical support levels while others argue the sharp sell-off is a major overreaction presenting a long-term value opportunity.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors weigh significant analyst price target hikes and bullish sentiment surrounding its upcoming Advancing AI event against broader volatility and uncertainty in the semiconductor sector. The community is actively debating the sustainability of the AI-driven rally, with many focusing on whether recent supply chain developments and increased capital expenditures justify current valuation levels.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened market attention and volatility driven by recent FDA acceptance of sNDA submissions for its Duchenne muscular dystrophy therapies, which has fueled speculation regarding potential acquisition interest. While the community remains deeply divided between long-term investors tracking pipeline developments and frustrated shareholders venting about persistent price stagnation and management performance, active discussions currently focus on whether these regulatory milestones and high short interest create a setup for a sustained price rerating or a potential buyout.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as a follow-on production order from a lead silicon photonics customer signals a shift from early evaluation to high-volume manufacturing for AI infrastructure. The community is actively debating the stock's valuation relative to its revenue growth, while investors monitor the order momentum and backlog conversion as key indicators of the company's long-term scale.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.read...

Curis Consents First Six Patients in TakeAim CLL Study

Curis Consents First Six Patients in TakeAim CLL Study Curis Consents First Six Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 6, 2026 LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...

Why Did Curis (CRIS) Stock Soar After Hours?

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stock split will take effect on Thursday.read more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million.
Humacyte (NASDAQ:HUMA) shares moved upwards by 5.45% to $0.71.read more...

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of...

Curis Reports Q1 2026 Results: Full Earnings Call Transcript

Curis Provides First Quarter 2026 Business Update

Curis Provides First Quarter 2026 Business Update Curis Provides First Quarter 2026 Business Update PR Newswire LEXINGTON, Mass., May 12, 2026 Management to host conference call today at 4:30 p.m...

Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 PR Newswire LEXINGTON, Mass., May 5, 2026 LEXINGTON, Mass...

Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) delivered earnings and revenue surprises of +50.00% and +5.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Curis Inc

Bearish Sentiment

$100+

$80 - $99.99

$70 - $79.99

$60 - $69.99

Stripe and private equity firm Advent International just submitted a joint takeover offer for PayPal ($PYPL) at $60.50 per share, valuing the company at more than $53 billion - a roughly 28% premium to Tuesday's close. What do you think PayPal is really worth? Cast your vote and explain your reasoning in the comments.

What should PayPal ($PYPL) be worth in a takeover deal?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$8.25	--	--	N/A
Q1 '26	-$0.33	-$25.00	-7553.05%	MISSED
Q4 '25	-$0.44	$1.23	382.11%	BEAT
Q3 '25	-$0.58	-$0.49	15.22%	BEAT
Q2 '25	-$1.36	-$0.68	50.00%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRISCuris Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CRIS News